Does Conscious Connected Breathwork Reduce Symptoms of Anxiety?

April 18, 2024 updated by: Richard Blake

Does Conscious Connected Breathwork Reduces Symptoms of Anxiety. A Quantitative Study Conducted in an Online Environment

The goal of this clinical trial is to test whether conscious connected breathwork reduces symptoms of anxiety in people with mild to severe anxiety symptoms, as measured by the Zung Self Rating Anxiety Scale.

The main questions aims to answer:

  1. Does conscious connected breathwork reduce symptoms of anxiety?
  2. Does an increased frequency of self-practice lead to even greater reductions of anxiety symptoms.

there is a comparison group: Researchers will compare whether people doing the breathwork to see if [insert effects].

Participants will participate in 1, 90 minute breath workshop per week for 6 weeks. These sessions will be held on Zoom by 2 facilitators. Participants will also be given a 10 minute recording of a guided conscious connected breathwork session that they will be encouraged to complete daily.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

108

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • California
      • San Francisco, California, United States, 94103
        • CIIS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

- Scores of 35 or higher on the Zung self-rating anxiety scale

Exclusion Criteria:

  • anyone having completed more than 4 sessions of Conscious Connected Breathwork
  • Anyone who has recently (within 1 year) started anti-depressant medication or psychotherapy
  • Anyone with a history of panic disorder, psychosis, angina, pregnant, seizure disorder, glaucoma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Breathwork Group
This group participated in 6 weeks of 90-minute Conscious Connected Breathwork groups conducted via Zoom. Participants attended 1 workshop per week
Behavioral: Conscious Connected Breathwork
Participants were taught the Conscious Connected Breathwork Technique. 2 facilitators were monitoring and coaching the participants to ensure adherence to the technique
Placebo Comparator: Waitlist control group
This group were told the 1st cohort of the study was full and they would be permitted to join cohort 2 in 6 weeks time. At the end of this waitlist period participants were invited to join the second cohort so long as they still met the inclusion criteria.
Other: Placebo waitlist
Participants were told the study was full and that they were placed on a waiting list until the 1st cohort had completed the breathwork program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in anxiety symptoms
Time Frame: 6 - 8 weeks between taking the anxiety scale either before and after the breathwork program or remaining on the wait list
Scores on the Zung Self Rating Anxiety Scale - Scores range from a minimum of 20 and a maximum of 80. A higher score indicates more severe symptoms of anxiety than a lower score.
6 - 8 weeks between taking the anxiety scale either before and after the breathwork program or remaining on the wait list

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Richard Blake

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 21, 2023

Primary Completion (Actual)

December 20, 2023

Study Completion (Actual)

December 20, 2023

Study Registration Dates

First Submitted

April 16, 2024

First Submitted That Met QC Criteria

April 16, 2024

First Posted (Actual)

April 19, 2024

Study Record Updates

Last Update Posted (Actual)

April 22, 2024

Last Update Submitted That Met QC Criteria

April 18, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CCB1

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe